ImmunityBio (IBRX) Retained Earnings (2014 - 2026)
ImmunityBio's (IBRX) quarterly Retained Earnings came in at -$4.4 billion in Q1 2026, down 24.38% year-on-year from -$5.8 billion in Q1 2025, and down 15155.35% on a QoQ basis from $29.0 million in Q4 2025.
ImmunityBio (IBRX) Retained Earnings (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 13 years of Retained Earnings data on file, last reported at -$4.4 billion in Q1 2026.
- On a quarterly basis, Retained Earnings fell 24.38% year-over-year to -$4.4 billion in Q1 2026; TTM through Mar 2026 was -$4.4 billion, a 24.38% decrease from a year earlier, with the FY2025 full-year figure at $29.0 million, up 100.86% from the prior year.
- Retained Earnings for Q1 2026 stood at -$4.4 billion, down from $29.0 million in the prior quarter.
- Over the last five years, Retained Earnings for IBRX reached as high as $29.0 million in Q4 2025 and fell as low as -$4.4 billion in Q1 2026.
- Historically, Retained Earnings has averaged -$2.3 billion across 5 years, with a median of -$2.6 billion in 2023.
- On a YoY basis, Retained Earnings climbed as much as 100.86% in 2025 and fell as far as 50069814.29% in 2025.
- Year by year, Retained Earnings stood at -$2.4 billion in 2022, then slipped by 24.52% to -$3.0 billion in 2023, then retreated by 13.96% to -$3.4 billion in 2024, then surged by 100.86% to $29.0 million in 2025, then tumbled by 15155.35% to -$4.4 billion in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$4.4 billion in Q1 2026, $29.0 million in Q4 2025, and -$3.7 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | -4.36 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.36 Bn |
| Dec 31, 2025 | 28.96 Mn |
| Sep 30, 2025 | -3.70 Bn |
| Jun 30, 2025 | -3.60 Bn |
| Mar 31, 2025 | -3.50 Bn |
| Dec 31, 2024 | -3.38 Bn |
| Sep 30, 2024 | -3.32 Bn |
| Jun 30, 2024 | -3.20 Bn |
| Mar 31, 2024 | -7,000.00 |
| Dec 31, 2023 | -2.96 Bn |
| Sep 30, 2023 | 792,000.00 |
| Jun 30, 2023 | -2.63 Bn |
| Mar 31, 2023 | -33,000.00 |
| Dec 31, 2022 | -2.38 Bn |
| Sep 30, 2022 | -2.30 Bn |
| Jun 30, 2022 | -2.16 Bn |
| Mar 31, 2022 | -2.10 Bn |
| Dec 31, 2021 | -1.96 Bn |
| Sep 30, 2021 | 53,000.00 |
| Jun 30, 2021 | 37,000.00 |